Resveratrol promotes degradation of the human bile acid transporter ASBT (SLC10A2)
Authors:
- 28 March 2014
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 459 (2) , 301-312
Abstract
The sodium/bile acid co-transporter ASBT [apical sodium-dependent bile acid transporter; SLC10A2 (solute carrier family 10 member 2)] plays a key role in the enterohepatic recycling of the bile acids and indirectly contributes to cholesterol homoeostasis. ASBT inhibitors reportedly lower plasma triglyceride levels and increase HDL (high-density lipoprotein) cholesterol levels. RSV (resveratrol), a major constituent of red wine, is known to lower LDL (low-density lipoprotein) cholesterol levels, but its mechanism of action is still unclear. In the present study, we investigated the possible involvement of ASBT in RSV-mediated cholesterol-lowering effects. We demonstrate that RSV inhibits ASBT protein expression and function via a SIRT1 (sirtuin 1)-independent mechanism. The effect was specific to ASBT since other transporters involved in cholesterol homoeostasis, NTCP (SLC10A1), OSTα (SLC51A) and ABCG1 (ATP-binding cassette G1), remained unaffected. ASBT inhibition by RSV was reversed by proteasome inhibitors (MG-132 and lactacystin) and the ubiquitin inhibitor LDN57444, suggesting involvement of the ubiquitin-proteasome pathway. Immunoprecipitation revealed high levels of ubiquitinated ASBT after RSV treatment. Phosphorylation at Ser335 and Thr339 was shown previously to play a role in proteosomal degradation of rat ASBT. However, mutation at corresponding residues in rat ASBT revealed that phosphorylation does not contribute to RSV-mediated degradation of ASBT. Combined, our data indicate that RSV promotes ASBT degradation via the ubiquitin-proteasome pathway without requiring phosphorylation. We conclude that regulation of ASBT expression by RSV may have clinical relevance with regard to the observed cholesterol-lowering effects of RSV.Keywords
This publication has 42 references indexed in Scilit:
- Dietary resveratrol increases the expression of hepatic 7α-hydroxylase and ameliorates hypercholesterolemia in high-fat fed C57BL/6J miceLipids in Health and Disease, 2012
- SIRT1 Is Essential for Oncogenic Signaling by Estrogen/Estrogen Receptor α in Breast CancerCancer Research, 2011
- Transmembrane Helix 1 Contributes to Substrate Translocation and Protein Stability of Bile Acid Transporter SLC10A2Journal of Biological Chemistry, 2011
- Role of the Intestinal Bile Acid Transporters in Bile Acid and Drug Disposition2010
- FXR Acetylation Is Normally Dynamically Regulated by p300 and SIRT1 but Constitutively Elevated in Metabolic Disease StatesCell Metabolism, 2009
- A solution for stripping antibodies from polyvinylidene fluoride immunoblots for multiple reprobingAnalytical Biochemistry, 2009
- Bile acid transporters in health and diseaseXenobiotica, 2008
- Modulation of peroxisome proliferator–activated receptor γ stability and transcriptional activity in adipocytes by resveratrolMetabolism, 2008
- Resveratrol improves health and survival of mice on a high-calorie dietNature, 2006
- Resveratrol regulates the expression of LXR-α in human macrophagesBiochemical and Biophysical Research Communications, 2006